CDC recommends Pfizer or Moderna booster after J&J vaccine
Adults who received an initial J&J COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection, according to a study released yesterday by the Centers for Disease Control and Prevention. The study examined 80,287 emergency department/urgent care visits and 25,244 hospitalizations in 10 states between Dec. 16, 2021, and March 7, 2022, when omicron was the predominant variant, and found adults who received a Pfizer or Moderna booster after the J&J vaccine were better protected than those who received one or two J&J doses.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…